Logos Global Management LP Elevation Oncology, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 3,850,000 shares of ELEV stock, worth $2.35 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
3,850,000
Previous 3,850,000
-0.0%
Holding current value
$2.35 Million
Previous $10.4 Million
-0.0%
% of portfolio
0.98%
Previous 0.98%
Shares
2 transactions
Others Institutions Holding ELEV
# of Institutions
81Shares Held
52MCall Options Held
700Put Options Held
2.1K-
Farallon Capital Management LLC San Francisco, CA3.6MShares$2.2 Million0.05% of portfolio
-
Tang Capital Management LLC San Diego, CA3.06MShares$1.87 Million1.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.96MShares$1.8 Million0.47% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.73 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.49MShares$1.52 Million0.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $14.2M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...